Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China flag China · Delayed Price · Currency is CNY
9.33
-0.42 (-4.31%)
At close: May 21, 2026

SHA:688189 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
278.09301.52490.27665.76713.47730.67
Cash & Short-Term Investments
278.09301.52490.27665.76713.47730.67
Cash Growth
-49.47%-38.50%-26.36%-6.69%-2.35%-24.04%
Accounts Receivable
33.5942.51199.9563.74741.49590.81
Other Receivables
1.881.025.780.956.36207.56
Receivables
35.4743.53205.68564.69747.85798.37
Inventory
42.1835.8861.1730.3727.0161.43
Prepaid Expenses
--1.623.520.323.65
Other Current Assets
19.8918.919.617.527.5119.06
Total Current Assets
375.63399.83778.351,2721,4961,613
Property, Plant & Equipment
145.7150.08164.3186.29204.62229.74
Goodwill
---10.8510.8513.57
Other Intangible Assets
86.4888.87143.13124.28138.01158.41
Long-Term Deferred Tax Assets
34.2533.7451.1757.2654.8272.22
Long-Term Deferred Charges
126.11118.4277.564.1946.2340.48
Other Long-Term Assets
18.5318.537.994.653.913.27
Total Assets
786.7809.471,2221,7191,9552,131
Accounts Payable
29.3427.2339.5939.5537.5156.47
Accrued Expenses
7.788.3853.3931.9739.2656.34
Short-Term Debt
1010.03218.19322.95488.73385.44
Current Portion of Long-Term Debt
----50.8533.9
Current Portion of Leases
--0.710.710.681.13
Current Income Taxes Payable
1.361.460.571.22-
Current Unearned Revenue
4.171.961.7213.4813.327.21
Other Current Liabilities
36.1444.4725.6918.1716.0414.2
Total Current Liabilities
88.7993.52339.85428.04648.36674.67
Long-Term Debt
-----50.85
Long-Term Leases
--0.230.943.394.07
Long-Term Unearned Revenue
2.632.733.34.25.62
Long-Term Deferred Tax Liabilities
0.790.841.051.532.291.68
Total Liabilities
92.297.06344.13433.8658.24736.89
Common Stock
274.4274.4274.4274.4196140
Additional Paid-In Capital
1,1751,1751,1751,1751,2541,310
Retained Earnings
-653.37-640.12-503.22-146.32-135.45-56.62
Treasury Stock
-29.25-26.14-10---
Total Common Equity
767.2783.55936.591,3031,3141,393
Minority Interest
-72.7-71.14-58.29-17.92-17.990.79
Shareholders' Equity
694.5712.41878.311,2861,2961,394
Total Liabilities & Equity
786.7809.471,2221,7191,9552,131
Total Debt
1010.03219.12324.6543.65475.38
Net Cash (Debt)
268.09291.49271.15341.16169.82255.29
Net Cash Growth
-18.90%7.50%-20.52%100.89%-33.48%-58.59%
Net Cash Per Share
0.981.060.991.240.620.93
Filing Date Shares Outstanding
274.19274.34272.83274.4274.4274.4
Total Common Shares Outstanding
274.19274.34272.83274.4274.4274.4
Working Capital
286.85306.31438.5843.82847.82938.51
Book Value Per Share
2.802.863.434.754.795.08
Tangible Book Value
680.72694.68793.461,1681,1661,221
Tangible Book Value Per Share
2.482.532.914.264.254.45
Buildings
--220.56220.56220.27220.27
Machinery
--229.88270.67264.88262.76
Construction In Progress
--0.350.570.241.28
Source: S&P Global Market Intelligence. Standard template. Financial Sources.